1. Home
  2. RMD

as of 02-26-2026 9:35am EST

$254.96
+$2.43
+0.96%
Stocks Health Care Medical/Dental Instruments Nasdaq

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Founded: 1989 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 36.8B IPO Year: N/A
Target Price: $293.70 AVG Volume (30 days): 1.2M
Analyst Decision: Buy Number of Analysts: 11
Dividend Yield:
0.95%
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $199.92 - $293.81 Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 10.64% Revenue Growth (next year): 7.38%
P/E Ratio: 25.61 Index:
Free Cash Flow: N/A FCF Growth: +28.73%

Latest ResMed Inc. News

RMD Breaking Stock News: Dive into RMD Ticker-Specific Updates for Smart Investing

All RMD News

Share on Social Networks: